nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC22A3—Estradiol—osteoporosis	0.309	0.845	CbGbCtD
Methamphetamine—CYP2D6—Cholecalciferol—osteoporosis	0.0569	0.156	CbGbCtD
Methamphetamine—Pseudoephedrine—NFATC1—osteoporosis	0.0156	0.768	CrCbGaD
Methamphetamine—Psychotic disorder—Calcitriol—osteoporosis	0.00635	0.0228	CcSEcCtD
Methamphetamine—Constipation—Calcium Acetate—osteoporosis	0.00513	0.0184	CcSEcCtD
Methamphetamine—Psychotic disorder—Pamidronate—osteoporosis	0.00508	0.0183	CcSEcCtD
Methamphetamine—Constipation—Ergocalciferol—osteoporosis	0.00453	0.0163	CcSEcCtD
Methamphetamine—Hypersensitivity—Calcium Acetate—osteoporosis	0.00442	0.0159	CcSEcCtD
Methamphetamine—Diarrhoea—Calcium Acetate—osteoporosis	0.0041	0.0147	CcSEcCtD
Methamphetamine—Dizziness—Calcium Acetate—osteoporosis	0.00396	0.0142	CcSEcCtD
Methamphetamine—Palpitations—Estropipate—osteoporosis	0.00369	0.0132	CcSEcCtD
Methamphetamine—Agitation—Calcitriol—osteoporosis	0.0036	0.0129	CcSEcCtD
Methamphetamine—Palpitations—Ibandronate—osteoporosis	0.00354	0.0127	CcSEcCtD
Methamphetamine—Dyspepsia—Etidronic acid—osteoporosis	0.00346	0.0124	CcSEcCtD
Methamphetamine—Constipation—Etidronic acid—osteoporosis	0.00337	0.0121	CcSEcCtD
Methamphetamine—Urticaria—Etidronic acid—osteoporosis	0.00313	0.0112	CcSEcCtD
Methamphetamine—Insomnia—Estropipate—osteoporosis	0.00308	0.0111	CcSEcCtD
Methamphetamine—Dyspepsia—Estropipate—osteoporosis	0.003	0.0108	CcSEcCtD
Methamphetamine—Insomnia—Raloxifene—osteoporosis	0.00298	0.0107	CcSEcCtD
Methamphetamine—Insomnia—Ibandronate—osteoporosis	0.00295	0.0106	CcSEcCtD
Methamphetamine—Dyspepsia—Alendronate—osteoporosis	0.00295	0.0106	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Estropipate—osteoporosis	0.00294	0.0106	CcSEcCtD
Methamphetamine—Constipation—Estropipate—osteoporosis	0.00291	0.0105	CcSEcCtD
Methamphetamine—Dyspepsia—Raloxifene—osteoporosis	0.0029	0.0104	CcSEcCtD
Methamphetamine—Hypersensitivity—Etidronic acid—osteoporosis	0.0029	0.0104	CcSEcCtD
Methamphetamine—Insomnia—Calcitriol—osteoporosis	0.00289	0.0104	CcSEcCtD
Methamphetamine—Agitation—Pamidronate—osteoporosis	0.00288	0.0103	CcSEcCtD
Methamphetamine—Dyspepsia—Ibandronate—osteoporosis	0.00287	0.0103	CcSEcCtD
Methamphetamine—Constipation—Alendronate—osteoporosis	0.00287	0.0103	CcSEcCtD
Methamphetamine—Lacosamide—CA2—osteoporosis	0.00286	0.141	CrCbGaD
Methamphetamine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00285	0.0102	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00282	0.0101	CcSEcCtD
Methamphetamine—Constipation—Ibandronate—osteoporosis	0.00279	0.01	CcSEcCtD
Methamphetamine—Constipation—Calcitriol—osteoporosis	0.00273	0.00981	CcSEcCtD
Methamphetamine—Urticaria—Estropipate—osteoporosis	0.00271	0.00971	CcSEcCtD
Methamphetamine—Diarrhoea—Etidronic acid—osteoporosis	0.00269	0.00967	CcSEcCtD
Methamphetamine—Tremor—Zoledronate—osteoporosis	0.00268	0.00963	CcSEcCtD
Methamphetamine—Urticaria—Alendronate—osteoporosis	0.00266	0.00957	CcSEcCtD
Methamphetamine—Agitation—Zoledronate—osteoporosis	0.00263	0.00945	CcSEcCtD
Methamphetamine—Urticaria—Ibandronate—osteoporosis	0.00259	0.00931	CcSEcCtD
Methamphetamine—Urticaria—Calcitriol—osteoporosis	0.00254	0.00912	CcSEcCtD
Methamphetamine—Palpitations—Zoledronate—osteoporosis	0.00253	0.00908	CcSEcCtD
Methamphetamine—Hypersensitivity—Estropipate—osteoporosis	0.00251	0.00901	CcSEcCtD
Methamphetamine—Tachycardia—Pamidronate—osteoporosis	0.0025	0.00896	CcSEcCtD
Methamphetamine—Hypersensitivity—Alendronate—osteoporosis	0.00247	0.00887	CcSEcCtD
Methamphetamine—Headache—Etidronic acid—osteoporosis	0.00247	0.00885	CcSEcCtD
Methamphetamine—Palpitations—Conjugated Estrogens—osteoporosis	0.00244	0.00875	CcSEcCtD
Methamphetamine—Insomnia—Risedronate—osteoporosis	0.00243	0.00874	CcSEcCtD
Methamphetamine—Hypersensitivity—Ibandronate—osteoporosis	0.00241	0.00864	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00238	0.00856	CcSEcCtD
Methamphetamine—Dyspepsia—Risedronate—osteoporosis	0.00237	0.00851	CcSEcCtD
Methamphetamine—Constipation—Ethinyl Estradiol—osteoporosis	0.00236	0.00847	CcSEcCtD
Methamphetamine—Hypersensitivity—Calcitriol—osteoporosis	0.00235	0.00846	CcSEcCtD
Methamphetamine—Diarrhoea—Estropipate—osteoporosis	0.00233	0.00837	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00232	0.00834	CcSEcCtD
Methamphetamine—Insomnia—Pamidronate—osteoporosis	0.00231	0.00831	CcSEcCtD
Methamphetamine—Constipation—Risedronate—osteoporosis	0.0023	0.00826	CcSEcCtD
Methamphetamine—Diarrhoea—Alendronate—osteoporosis	0.00229	0.00824	CcSEcCtD
Methamphetamine—Tachycardia—Zoledronate—osteoporosis	0.00228	0.00819	CcSEcCtD
Methamphetamine—Diarrhoea—Raloxifene—osteoporosis	0.00226	0.0081	CcSEcCtD
Methamphetamine—Dyspepsia—Pamidronate—osteoporosis	0.00225	0.00809	CcSEcCtD
Methamphetamine—Dizziness—Estropipate—osteoporosis	0.00225	0.00809	CcSEcCtD
Methamphetamine—Diarrhoea—Ibandronate—osteoporosis	0.00223	0.00802	CcSEcCtD
Methamphetamine—Dizziness—Alendronate—osteoporosis	0.00222	0.00796	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00221	0.00793	CcSEcCtD
Methamphetamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.0022	0.00788	CcSEcCtD
Methamphetamine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00219	0.00787	CcSEcCtD
Methamphetamine—Constipation—Pamidronate—osteoporosis	0.00219	0.00785	CcSEcCtD
Methamphetamine—Diarrhoea—Calcitriol—osteoporosis	0.00219	0.00785	CcSEcCtD
Methamphetamine—Dizziness—Raloxifene—osteoporosis	0.00218	0.00783	CcSEcCtD
Methamphetamine—Dizziness—Ibandronate—osteoporosis	0.00216	0.00775	CcSEcCtD
Methamphetamine—Urticaria—Risedronate—osteoporosis	0.00214	0.00768	CcSEcCtD
Methamphetamine—Headache—Estropipate—osteoporosis	0.00213	0.00766	CcSEcCtD
Methamphetamine—Insomnia—Zoledronate—osteoporosis	0.00211	0.00759	CcSEcCtD
Methamphetamine—Headache—Alendronate—osteoporosis	0.0021	0.00754	CcSEcCtD
Methamphetamine—Tremor—Estradiol—osteoporosis	0.00207	0.00742	CcSEcCtD
Methamphetamine—Headache—Raloxifene—osteoporosis	0.00207	0.00742	CcSEcCtD
Methamphetamine—Dyspepsia—Zoledronate—osteoporosis	0.00206	0.00739	CcSEcCtD
Methamphetamine—Headache—Ibandronate—osteoporosis	0.00205	0.00734	CcSEcCtD
Methamphetamine—Insomnia—Conjugated Estrogens—osteoporosis	0.00203	0.00731	CcSEcCtD
Methamphetamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00203	0.0073	CcSEcCtD
Methamphetamine—Agitation—Estradiol—osteoporosis	0.00203	0.00728	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00202	0.00724	CcSEcCtD
Methamphetamine—Headache—Calcitriol—osteoporosis	0.002	0.00719	CcSEcCtD
Methamphetamine—Constipation—Zoledronate—osteoporosis	0.002	0.00717	CcSEcCtD
Methamphetamine—Hypersensitivity—Risedronate—osteoporosis	0.00198	0.00712	CcSEcCtD
Methamphetamine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00198	0.00711	CcSEcCtD
Methamphetamine—Palpitations—Estradiol—osteoporosis	0.00195	0.007	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00194	0.00697	CcSEcCtD
Methamphetamine—Constipation—Conjugated Estrogens—osteoporosis	0.00192	0.00691	CcSEcCtD
Methamphetamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00189	0.00678	CcSEcCtD
Methamphetamine—Hypersensitivity—Pamidronate—osteoporosis	0.00188	0.00677	CcSEcCtD
Methamphetamine—Urticaria—Zoledronate—osteoporosis	0.00186	0.00667	CcSEcCtD
Methamphetamine—Diarrhoea—Risedronate—osteoporosis	0.00184	0.00661	CcSEcCtD
Methamphetamine—Pseudoephedrine—TNF—osteoporosis	0.00183	0.0902	CrCbGaD
Methamphetamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00183	0.00655	CcSEcCtD
Methamphetamine—Urticaria—Conjugated Estrogens—osteoporosis	0.00179	0.00642	CcSEcCtD
Methamphetamine—Dizziness—Risedronate—osteoporosis	0.00178	0.00639	CcSEcCtD
Methamphetamine—Tachycardia—Estradiol—osteoporosis	0.00176	0.00631	CcSEcCtD
Methamphetamine—Diarrhoea—Pamidronate—osteoporosis	0.00175	0.00628	CcSEcCtD
Methamphetamine—Headache—Ethinyl Estradiol—osteoporosis	0.00173	0.00621	CcSEcCtD
Methamphetamine—Hypersensitivity—Zoledronate—osteoporosis	0.00172	0.00618	CcSEcCtD
Methamphetamine—Dizziness—Pamidronate—osteoporosis	0.00169	0.00607	CcSEcCtD
Methamphetamine—Headache—Risedronate—osteoporosis	0.00169	0.00605	CcSEcCtD
Methamphetamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00166	0.00595	CcSEcCtD
Methamphetamine—Insomnia—Estradiol—osteoporosis	0.00163	0.00585	CcSEcCtD
Methamphetamine—Headache—Pamidronate—osteoporosis	0.0016	0.00575	CcSEcCtD
Methamphetamine—Diarrhoea—Zoledronate—osteoporosis	0.0016	0.00574	CcSEcCtD
Methamphetamine—Dyspepsia—Estradiol—osteoporosis	0.00159	0.00569	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Estradiol—osteoporosis	0.00155	0.00558	CcSEcCtD
Methamphetamine—Dizziness—Zoledronate—osteoporosis	0.00155	0.00555	CcSEcCtD
Methamphetamine—Constipation—Estradiol—osteoporosis	0.00154	0.00553	CcSEcCtD
Methamphetamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00154	0.00553	CcSEcCtD
Methamphetamine—Dizziness—Conjugated Estrogens—osteoporosis	0.00149	0.00534	CcSEcCtD
Methamphetamine—Headache—Zoledronate—osteoporosis	0.00146	0.00526	CcSEcCtD
Methamphetamine—Urticaria—Estradiol—osteoporosis	0.00143	0.00514	CcSEcCtD
Methamphetamine—Headache—Conjugated Estrogens—osteoporosis	0.00141	0.00506	CcSEcCtD
Methamphetamine—Hypersensitivity—Estradiol—osteoporosis	0.00133	0.00476	CcSEcCtD
Methamphetamine—Diarrhoea—Estradiol—osteoporosis	0.00123	0.00442	CcSEcCtD
Methamphetamine—Dizziness—Estradiol—osteoporosis	0.00119	0.00428	CcSEcCtD
Methamphetamine—Headache—Estradiol—osteoporosis	0.00113	0.00405	CcSEcCtD
Methamphetamine—MAOA—Metabolism—CYP27A1—osteoporosis	0.000184	0.000547	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—LEP—osteoporosis	0.000181	0.000538	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ACP5—osteoporosis	0.000179	0.000533	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SOST—osteoporosis	0.000179	0.000532	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000178	0.000531	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PTH—osteoporosis	0.000177	0.000527	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000177	0.000526	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—POMC—osteoporosis	0.000177	0.000526	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—WNT1—osteoporosis	0.000174	0.000517	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PTHLH—osteoporosis	0.000173	0.000515	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000173	0.000515	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ESR1—osteoporosis	0.000172	0.000514	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CNR2—osteoporosis	0.000172	0.000514	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MGLL—osteoporosis	0.000169	0.000504	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—TPI1—osteoporosis	0.000166	0.000495	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LRP5—osteoporosis	0.000165	0.000492	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ENO1—osteoporosis	0.000163	0.000485	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—WNT1—osteoporosis	0.000162	0.000483	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTH1R—osteoporosis	0.000162	0.000482	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALCR—osteoporosis	0.000162	0.000482	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PTHLH—osteoporosis	0.000161	0.000481	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IRS1—osteoporosis	0.000161	0.00048	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—IDH2—osteoporosis	0.000161	0.000479	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PSMA5—osteoporosis	0.00016	0.000478	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PSMA2—osteoporosis	0.00016	0.000478	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000159	0.000475	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—IL6—osteoporosis	0.000159	0.000473	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PTH—osteoporosis	0.000158	0.000472	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MGLL—osteoporosis	0.000158	0.000471	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LRP6—osteoporosis	0.000158	0.000471	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CA2—osteoporosis	0.000158	0.000469	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—OXCT1—osteoporosis	0.000158	0.000469	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PTHLH—osteoporosis	0.000157	0.000468	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000156	0.000466	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—P4HB—osteoporosis	0.000156	0.000465	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—POMC—osteoporosis	0.000155	0.000462	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LRP5—osteoporosis	0.000154	0.00046	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	0.000154	0.00046	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CYP19A1—osteoporosis	0.000154	0.000458	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MGLL—osteoporosis	0.000154	0.000457	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GAPDH—osteoporosis	0.000153	0.000457	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CALCA—osteoporosis	0.000152	0.000453	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6R—osteoporosis	0.000151	0.000451	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CYP27A1—osteoporosis	0.000151	0.00045	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—RAP1A—osteoporosis	0.000149	0.000445	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IGF1—osteoporosis	0.000149	0.000445	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—POMC—osteoporosis	0.000148	0.00044	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LRP6—osteoporosis	0.000148	0.00044	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ACP5—osteoporosis	0.000147	0.000438	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PTHLH—osteoporosis	0.000147	0.000437	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PTH—osteoporosis	0.000144	0.000428	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CALCA—osteoporosis	0.000142	0.000423	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000141	0.00042	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—POMC—osteoporosis	0.000141	0.00042	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00014	0.000418	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	0.00014	0.000417	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PKM—osteoporosis	0.000139	0.000415	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—FDPS—osteoporosis	0.000139	0.000415	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CALCA—osteoporosis	0.000138	0.000412	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TPI1—osteoporosis	0.000137	0.000407	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TLN1—osteoporosis	0.000133	0.000397	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PGLS—osteoporosis	0.000132	0.000393	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GPD2—osteoporosis	0.000132	0.000393	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	0.000132	0.000392	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000132	0.000392	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—POMC—osteoporosis	0.000132	0.000392	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	0.000131	0.000391	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—IDH2—osteoporosis	0.000131	0.000389	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CYP19A1—osteoporosis	0.00013	0.000388	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CALCA—osteoporosis	0.000129	0.000385	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—P4HB—osteoporosis	0.000128	0.000383	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MGLL—osteoporosis	0.000128	0.000383	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GAPDH—osteoporosis	0.000126	0.000376	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ADCY5—osteoporosis	0.000126	0.000374	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LRP5—osteoporosis	0.000125	0.000373	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—GPX1—osteoporosis	0.000125	0.000373	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TLN1—osteoporosis	0.000125	0.000371	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—RAP1A—osteoporosis	0.000123	0.000366	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP27A1—osteoporosis	0.000123	0.000366	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IGF1—osteoporosis	0.000121	0.000361	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ATIC—osteoporosis	0.000121	0.00036	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PNP—osteoporosis	0.000121	0.00036	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ENO1—osteoporosis	0.000121	0.00036	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LRP6—osteoporosis	0.00012	0.000357	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ACP5—osteoporosis	0.000119	0.000356	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	0.000119	0.000355	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PSMA5—osteoporosis	0.000119	0.000354	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PSMA2—osteoporosis	0.000119	0.000354	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—MTHFR—osteoporosis	0.000116	0.000344	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	0.000115	0.000344	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—P4HB—osteoporosis	0.000115	0.000343	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—IL6—osteoporosis	0.000114	0.00034	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IGF1—osteoporosis	0.000113	0.000337	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTH—osteoporosis	0.000112	0.000333	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TPI1—osteoporosis	0.000111	0.000331	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RAP1A—osteoporosis	0.00011	0.000328	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CNR2—osteoporosis	0.000109	0.000325	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—ADCY5—osteoporosis	0.000108	0.000322	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—P4HB—osteoporosis	0.000107	0.00032	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NFATC1—osteoporosis	0.000107	0.00032	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000107	0.000319	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—POMC—osteoporosis	0.000107	0.000318	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—DKK1—osteoporosis	0.000106	0.000317	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ADCY5—osteoporosis	0.000106	0.000317	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—GPX1—osteoporosis	0.000106	0.000316	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	0.000105	0.000312	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTH—osteoporosis	0.000105	0.000311	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—P4HB—osteoporosis	0.000104	0.000311	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RAP1A—osteoporosis	0.000103	0.000306	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—OXCT1—osteoporosis	0.000103	0.000306	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CA2—osteoporosis	0.000103	0.000306	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—WNT1—osteoporosis	0.000103	0.000305	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GAPDH—osteoporosis	0.000102	0.000305	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CNR2—osteoporosis	0.000102	0.000303	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TLN1—osteoporosis	0.000101	0.000302	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—ADCY5—osteoporosis	0.000101	0.000301	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NFATC1—osteoporosis	0.0001	0.000299	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MGLL—osteoporosis	0.0001	0.000298	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—RAP1A—osteoporosis	9.98e-05	0.000297	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGA—osteoporosis	9.97e-05	0.000297	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—DKK1—osteoporosis	9.94e-05	0.000296	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ENO1—osteoporosis	9.93e-05	0.000296	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	9.83e-05	0.000293	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PSMA5—osteoporosis	9.78e-05	0.000292	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PSMA2—osteoporosis	9.78e-05	0.000292	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—MTHFR—osteoporosis	9.78e-05	0.000291	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CYP19A1—osteoporosis	9.65e-05	0.000288	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—WNT1—osteoporosis	9.58e-05	0.000285	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGA—osteoporosis	9.32e-05	0.000278	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BMP2—osteoporosis	9.27e-05	0.000276	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	9.27e-05	0.000276	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—POMC—osteoporosis	9.24e-05	0.000275	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IGF1—osteoporosis	9.19e-05	0.000274	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	9.18e-05	0.000274	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGB—osteoporosis	9.07e-05	0.00027	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—MYC—osteoporosis	8.97e-05	0.000267	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TGFB1—osteoporosis	8.95e-05	0.000267	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	8.76e-05	0.000261	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	8.76e-05	0.000261	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	8.73e-05	0.00026	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	8.66e-05	0.000258	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BMP2—osteoporosis	8.66e-05	0.000258	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—IDH2—osteoporosis	8.51e-05	0.000253	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTH—osteoporosis	8.49e-05	0.000253	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGB—osteoporosis	8.47e-05	0.000253	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	8.34e-05	0.000249	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	8.27e-05	0.000247	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	8.21e-05	0.000245	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	8.18e-05	0.000244	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	8.18e-05	0.000244	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CALCA—osteoporosis	8.16e-05	0.000243	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	8.14e-05	0.000243	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	8.07e-05	0.000241	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ENO1—osteoporosis	8.07e-05	0.00024	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP27A1—osteoporosis	8e-05	0.000238	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	7.96e-05	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PSMA2—osteoporosis	7.95e-05	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PSMA5—osteoporosis	7.95e-05	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CYP19A1—osteoporosis	7.94e-05	0.000237	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ADCY5—osteoporosis	7.88e-05	0.000235	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GPX1—osteoporosis	7.86e-05	0.000234	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—POMC—osteoporosis	7.82e-05	0.000233	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ACP5—osteoporosis	7.78e-05	0.000232	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	7.78e-05	0.000232	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CALCA—osteoporosis	7.62e-05	0.000227	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGA—osteoporosis	7.57e-05	0.000225	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	7.46e-05	0.000222	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	7.44e-05	0.000222	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KL—osteoporosis	7.41e-05	0.000221	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TGFB1—osteoporosis	7.26e-05	0.000216	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—MTHFR—osteoporosis	7.25e-05	0.000216	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TPI1—osteoporosis	7.23e-05	0.000216	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—POMC—osteoporosis	7.23e-05	0.000215	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	7.05e-05	0.00021	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	7.03e-05	0.00021	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	7.03e-05	0.00021	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KL—osteoporosis	6.92e-05	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGB—osteoporosis	6.88e-05	0.000205	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—P4HB—osteoporosis	6.8e-05	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TGFB1—osteoporosis	6.79e-05	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—POMC—osteoporosis	6.75e-05	0.000201	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—osteoporosis	6.74e-05	0.000201	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GAPDH—osteoporosis	6.68e-05	0.000199	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	6.65e-05	0.000198	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	6.65e-05	0.000198	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	6.59e-05	0.000196	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—RAP1A—osteoporosis	6.5e-05	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ADCY5—osteoporosis	6.49e-05	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GPX1—osteoporosis	6.46e-05	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP19A1—osteoporosis	6.45e-05	0.000192	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	6.19e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	6.04e-05	0.00018	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MTHFR—osteoporosis	5.96e-05	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	5.81e-05	0.000173	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—POMC—osteoporosis	5.8e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KL—osteoporosis	5.62e-05	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	5.62e-05	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—osteoporosis	5.51e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	5.48e-05	0.000163	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	5.42e-05	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	5.35e-05	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ADCY5—osteoporosis	5.27e-05	0.000157	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ENO1—osteoporosis	5.26e-05	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GPX1—osteoporosis	5.25e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	5.25e-05	0.000156	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PSMA5—osteoporosis	5.18e-05	0.000154	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PSMA2—osteoporosis	5.18e-05	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	5.08e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LEP—osteoporosis	4.97e-05	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MTHFR—osteoporosis	4.85e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—osteoporosis	4.77e-05	0.000142	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	4.75e-05	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	4.74e-05	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LEP—osteoporosis	4.64e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	4.43e-05	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	4.43e-05	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	4.4e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—osteoporosis	4.27e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	4.26e-05	0.000127	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.2e-05	0.000125	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	4.17e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	4.14e-05	0.000123	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	4.11e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—osteoporosis	3.99e-05	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	3.89e-05	0.000116	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—osteoporosis	3.87e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	3.85e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	3.84e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LEP—osteoporosis	3.77e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	3.6e-05	0.000107	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADCY5—osteoporosis	3.43e-05	0.000102	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GPX1—osteoporosis	3.42e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	3.36e-05	0.0001	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—osteoporosis	3.24e-05	9.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	3.16e-05	9.42e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MTHFR—osteoporosis	3.16e-05	9.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	3.14e-05	9.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	3.12e-05	9.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	2.93e-05	8.74e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—osteoporosis	2.52e-05	7.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MYC—osteoporosis	2.47e-05	7.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	2.46e-05	7.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	2.38e-05	7.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MYC—osteoporosis	2.31e-05	6.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	2.3e-05	6.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MYC—osteoporosis	1.87e-05	5.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	1.87e-05	5.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—osteoporosis	1.86e-05	5.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—osteoporosis	1.73e-05	5.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—osteoporosis	1.41e-05	4.2e-05	CbGpPWpGaD
